14 results
6-K
EX-99.4
SOPH
SOPHiA Genetics SA
7 May 24
Index to Consolidated Financial Statements
7:01am
, distribution, testing, packaging, purchasing or other commercialization activities, receipt of payment in respect of any of the foregoing (including … , including (a) brand materials, packaging and other trade dress, customer targeting and other marketing, promotion and sales materials and information
6-K
EX-1.1
SOPH
SOPHiA Genetics SA
8 Aug 23
Current report (foreign)
5:17pm
and Drug Administration (“FDA”) and other comparable governmental entities applicable to the ownership, testing, development, manufacture, packaging
20-F
2021 FY
EX-4.11
SOPH
SOPHiA Genetics SA
15 Mar 22
Annual report (foreign)
7:24am
Specifications until the expiration dates specified on the Product packaging, or if not specified, then [**] from the date that NEB delivers such Product
20-F
2021 FY
SOPH
SOPHiA Genetics SA
15 Mar 22
Annual report (foreign)
7:24am
, control, quality assurance, labeling, packaging, servicing, sterilization (if required), and storage and shipping of medical devices (among other … ;
laboratory and clinical testing, labeling, packaging, storage and distribution;
product safety and efficacy;
premarketing clearance or approval
424B4
slfp67lqiv
23 Jul 21
Prospectus supplement with pricing info
4:37pm
F-1/A
EX-1.1
cqya3lk6meftu6y
19 Jul 21
Registration statement (foreign) (amended)
7:01am
F-1/A
f5gsi
19 Jul 21
Registration statement (foreign) (amended)
7:01am
F-1
EX-10.7
0ulwpjqtg
2 Jul 21
Registration statement (foreign)
4:17pm
F-1
0ocel6t67j
2 Jul 21
Registration statement (foreign)
4:17pm
F-1
EX-10.9
vg7r81o
2 Jul 21
Registration statement (foreign)
4:17pm
DRS
EX-10.7
2iqvu1q9nylhrq
24 May 21
Draft registration statement
12:00am
DRS
EX-10.9
tbw1735rg4ddmbokj
24 May 21
Draft registration statement
12:00am
DRS
9d7p68ov
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next